Hot off the Press...New Hypertension and Dyslipidemia Guidelines: Midyear Highlights
Treatment of hypertension and dyslipidemia are two of the most common cardiovascular risk reduction strategies, and management of these risk factors is considered a standard of care. However, national guidelines that recommend standards for treatment are outdated. Participants will apply the latest information from clinical trials to patient cases to assess management options for hypertension and dyslipidemia in this application-based activity, a recording of an educational session that occurred at The Midyear 2012 in Las Vegas on December 6, 2012.
Click here to go to the collection of the 2012 Midyear Highlights activities.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This application-based activity provides 2.0 hours (0.20 CEUs) of continuing pharmacy education credits (0204-0000-12-257-H01P).
Expiration Date: December 3, 2015
Faculty
Joel C. Marrs, PharmD, BCPS
Assistant Professor, University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora
Joseph J. Saseen, PharmD, BCPS, FASHP
Professor and Vice Chair, University of Colorado, Aurora
Learning Objectives
After participating in this application-based CPE activity, participants should be able to:
- Describe clinical controversies related to the treatment of hypertension and dyslipidemia.
- Summarize the JNC 8 and NCEP ATP 4 guidelines for the management of hypertension and dyslipidemia.
- Identify how clinical trials evidence support recommendations in the JNC 8 and NCEP ATP 4 guidelines.
- Evaluate therapy that effectively implements new JNC 8 and NCEP ATP 4 guidelines
Target Audience
This continuing pharmacy education activity was planned to meet the needs of pharmacists.
Methods and Format
This recorded activity consists of audio recordings, slide presentation and an activity evaluation tool. Participants must listen, view the content in its entirety, and complete the test and evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately following the activity.
Disclosure Statement
ASHP requires all individuals who have control in planning or presenting educational content disclose all relevant financial relationships with any commercial interest. ASHP identifies and resolves conflicts of interest prior to an individual‘s participation in the development of content for an educational activity. This is in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Commercial Support and the Accreditation Council for Pharmacy Education (ACPE) Guidelines for Standards for Commercial Support.
The faculty and planners report no relevant financial relationships exist pertinent to this activity except:
- Joel C. Marrs, Board Member: National Lipid Association Southwest Chapter
- Joseph J. Saseen, Board Member: Board of Pharmacy Specialities, National Lipid Association